Skip to main content

Table 5 Incidence of adverse events as a function of parasitaemia

From: Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire

  Positive parasitaemia Negative parasitaemia Undetermined parasitaemia p
N = 11,141 N = 3435 N = 585
Any AE 12.9% [12.3%; 13.5%] 13.7% [12.5%; 14.8%] 11.8% [9.2%; 14.4%] 0.333
Any SAE 0.7% [0.5%; 0.8%] 0.6% [0.4%; 0.9%] 0.5% [0.0%; 1.1%] 0.905
Any potentially ASAQ-related AE 5.6% [5.2%; 6.1%] 5.4% [4.6%; 6.1%] 4.4% [2.8%; 6.1%] 0.423
  1. The occurrence of adverse events is presented as the incidence rate (%) with its 95% confidence interval